From GlobeNewswire:

Akoya Biosciences has announced a new license and distribution agreement with Thermo Fisher Scientific. The goal of the agreement is to combine Akoya and Thermo Fisher’s technologies to create high-plex, high-throughput spatial proteomics solutions for researchers. The partnership is expected to streamline the progression of biomarker programs from discovery to diagnostics. CEO Brian McKelligon highlighted the excitement of both companies as they strive to further advance the spatial biology field. Akoya Biosciences is known as The Spatial Biology Company® and is dedicated to bringing context to the world of biology and human health.



Read more: Akoya Biosciences and Thermo Fisher Scientific Announce a